Prosecution Insights
Last updated: November 20, 2026
Application No. 18/945,758

MEDICAL DEVICES WITH A NEGATIVE PRESSURE SOURCE AND RELATED SYSTEMS AND METHODS OF USE

Non-Final OA §102§103
Filed
Nov 13, 2024
Priority
Nov 15, 2023 — provisional 63/599,056
Examiner
YANG, CHENG FONG
Art Unit
3781
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Boston Scientific Corporation
OA Round
1 (Non-Final)
62%
Grant Probability
Moderate
1-2
OA Rounds
1y 1m
Est. Remaining
86%
With Interview

Examiner Intelligence

Grants 62% of resolved cases
62%
Career Allowance Rate
100 granted / 161 resolved
-7.9% vs TC avg
Strong +24% interview lift
Without
With
+24.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
54 currently pending
Career history
205
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
50.7%
+10.7% vs TC avg
§102
23.6%
-16.4% vs TC avg
§112
19.8%
-20.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 161 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 16-20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected species, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 2 October 2026. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-8 and 10-13 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Blott et al. (US 20110213319 A1). Regarding Claim 1, Blott discloses a medical device system ("apparatus (1) for aspirating, irrigating, and/or cleansing wounds" [0449]; FIG. 1) comprising: a bag ("collection bag (not shown)" [0449]; FIG. 1) including a first opening (inlet of collection bag [0449]); a pad ("conformable wound dressing (2)" [0449]; FIG. 1) coupled to the bag proximate to the first opening ("a container that contains a cell or tissue component (12b) connected to the supply tube (7), and the outlet pipe (9) being connected via means for aspirate flow regulation, here a valve (16) and a fluid offtake tube (10) to waste, e.g. to a collection bag (not shown)" [0449]; FIG. 1); and a tube including a distal portion ("first tube (101) extending from the inlet pipe (46), and second tube (102) extending from the outlet pipe (47)" [0486]; FIG. 8a), wherein the distal portion is coupled to the pad ("points at which they pass through the backing layer, to run over the scaffold and/or wound bed" [0486]) and includes at least one opening ("orifices (103) and (104)" [0487]); wherein the tube is configured to provide negative pressure therapy to a wound site ("supplying optionally varying positive and/or negative pressure, which is optionally pulsed, to a wound bed and optionally tissue surrounding the wound" [0378]). Regarding Claim 2, Blott discloses a pump assembly fluidically coupled to the tube, wherein the pump assembly applies negative pressure to the tube ("diaphragm pump (18), e.g. preferably a small portable diaphragm pump, acting on the fluid offtake tube (10) to apply a low negative pressure on the wound" [0449]; FIG. 1). Regarding Claim 3, Blott discloses the pad is circular ("circular backing layer (42)" [0457]; FIG. 3a) and includes a central lumen, and wherein the central lumen aligns with the first opening ("central tunnel (50)" [0458]; FIG. 3a). Regarding Claim 4, Blott discloses the distal portion of the tube extends circumferentially around the central lumen ("one layout of each of the pipes (101) and (102) as inlet pipe and outlet pipe manifolds is a spiral" [0489]; FIG. 8a). Regarding Claim 5, Blott discloses the at least one opening of the tube includes a plurality of openings ("orifices (103) and (104) along the pipes (101) and (102)" [0487]; FIG. 8a), and wherein the plurality of openings face a direction towards the pad ([0488]; FIG. 8a). Regarding Claim 6, Blott discloses a filter assembly coupled to the tube and configured to filter material received from the wound site ("macroscopic and/or microscopic filter for particulates including cell debris and micro-organisms" [0159]). Regarding Claim 7, Blott discloses the pump assembly includes a pump ("diaphragm pump, acting on the fluid offtake tube (10) to apply a low negative pressure on the wound" [0449]) and a reservoir configured to receive material from a wound site (the volume within the "collection bag (not shown)" [0449]). Regarding Claim 8, Blott discloses the pad includes a channel configured to receive the tube ("Through the sheet (111) pass the inlet pipe (46) and the outlet pipe (47)" [0493]), wherein the channel extends circumferentially around a central lumen of the pad ("Each extends in pipes (51) and (52) respectively through the tunnel (50) of the toroidal hollow body (48) and then radially in diametrically opposite directions under the body (48)" [0459]; FIG. 3a). Regarding Claim 10, Blott discloses the pad includes a first layer of porous material ("backing layer (42)" [0492]; FIG. 9b) and a second layer of porous material ("wound filler (110)" [0492]), and wherein a portion of the tube is positioned between the first layer of porous material and the second layer of porous material (see FIG. 9b). Regarding Claim 11, Blott discloses the pad includes an adhesive on a first side of the pad ("periphery of the wound-facing face of the backing layer may bear an adhesive film" [0108]), and wherein the adhesive extends across a first portion of the first side of the pad and not across a second portion of the first side of the pad ("periphery of the wound-facing face of the backing layer may bear an adhesive film" [0108]). Regarding Claim 12, Blott discloses a wafer ("backing layer may have a flange or lip extending around the proximal face of the backing layer" [0109]), wherein a first side of the wafer is configured to couple the bag to the wafer ("suction outlet that passes through the flange or lip to communicate with the channel or conduit and may be connected to a device for applying a vacuum" [0121]), and wherein a second side of the wafer is configured to couple the pad to the wafer ("backing layer may be integral with or attached, for example by heat-sealing, to the flange or lip" [0121]). Regarding Claim 13, Blott discloses the wafer includes a convex portion ("flange or lip is concave on its proximal face" [0121]), wherein the convex portion extends circumferentially around a central lumen of the wafer ("flange or lip extends around the periphery of the proximal face of the backing layer of the wound dressing" [0120]), and wherein the tube is positioned radially-outward, relative to a central longitudinal axis of the central lumen ("Each extends in pipes (51) and (52) respectively through the tunnel (50) of the toroidal hollow body (48) and then radially in diametrically opposite directions under the body (48)" [0459]), relative to the convex portion (see FIG. 9a). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 9 is/are rejected under 35 U.S.C. 103 as being unpatentable over Blott in view of Lattimore et al. (US 20110213287 A1). Regarding Claim 9, Blott fails to specify the pad includes a perforated portion configured to be removable from the pad. However, Lattimore teaches “a foam pad, which may be suitable for use in abdominal wound sites, and which may be sized in a dimensionally-independent manner” (Abstract) wherein the pad includes a perforated portion configured to be removable from the pad ("porous pad is perforated to allow removal of pad portions" [0011]). Therefore, it would have been obvious to one of ordinary skill in the art prior to the effective filing date of the claimed invention to modify the device of Blott to arrive at the claimed invention “to permit sizing of the pad in a dimensionally-independent manner to fit the wound site” ([0011]). Claim(s) 14 is/are rejected under 35 U.S.C. 103 as being unpatentable over Blott in view of Heiser et al. (US 20120316538 A1). Regarding Claim 14, Blott fails to specify the bag includes a pocket and the pump assembly is positioned within the pocket. However, Heiser teaches “a negative pressure wound therapy (NPWT) system” ([0003]) wherein the bag includes a pocket and the pump assembly is positioned within the pocket ("housing 102 defines multiple interior compartments or cavities. In one of those cavities, a pump 252 may be integrated within the housing 102" [0066]; FIG. 12). Therefore, it would have been obvious to modify the device of Blott to arrive at the claimed invention to improve “convenience and, or ease of use by placing or storing the pump in a quieter or more travel-friendly location” ([0054]). Claim(s) 15 is/are rejected under 35 U.S.C. 103 as being unpatentable over Blott in view of Subilski (US 20180043069 A1). Regarding Claim 15, Blott fails to specify the pad is C-shaped. However, Subilski teaches “a system and method for a modular external interface for a skin penetrating appliance” wherein the pad is C-shaped ("main body 516 with the slit 534 separated" [0039]; FIG. 13B). Therefore, it would have been obvious to modify the device of Blott to arrive at the claimed invention “to prevent wrinkling of the medical dressing where the main body 316, foam layer 326, and the subject's skin meet” ([0034]). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant’s disclosure. The references provided on the attached PTO-892 form are considered relevant to applicant’s disclosure and are cited to further show the general state of the art. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Cheng Fong "Ted" Yang whose telephone number is (571)272-8846. The examiner can normally be reached 10am - 6pm (EST) M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Rebecca E. Eisenberg can be reached at (571) 270-5879. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Cheng Fong "Ted" Yang Examiner Art Unit 3781 /REBECCA E EISENBERG/Supervisory Patent Examiner, Art Unit 3781
Read full office action

Prosecution Timeline

Nov 13, 2024
Application Filed
Oct 29, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12797093
THROMBECTOMY SYSTEMS AND METHODS FOR SAME
3y 10m to grant Granted Nov 17, 2026
Patent 12778789
COLLAPSIBLE MENSTRUAL CUP AND METHOD FOR ALLEVIATING MENSTRUAL DISCOMFORT
3y 0m to grant Granted Nov 03, 2026
Patent 12766263
PARTITIONED CARPULE, SYRINGE, AND SYSTEM THEREFOR, AND METHODS OF USE THEREOF
3y 10m to grant Granted Oct 20, 2026
Patent 12766304
CLOSING ELEMENT FOR A FLUID LINE
3y 7m to grant Granted Oct 20, 2026
Patent 12734282
BLOOD PURIFICATION APPARATUS
2y 10m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
62%
Grant Probability
86%
With Interview (+24.0%)
3y 2m (~1y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 161 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month